Normomed syrup is recommended to be applied at the following indications:
- infectious diseases of a virus etiology at patients with the normal and lowered immune status: flu, parainfluenza, acute respiratory viral infections, bronchitis of a virus etiology, rinovirusny and adenoviral infections; epidemic parotitis, measles (as a part of complex therapy);
- a disease, the caused viruses of a herpes simplex Herpes simplex of type I or II Herpes simplex (herpes of lips, face skin, mucous membrane of an oral cavity, skin of hands, oftalmogerpes), a subacute sclerosing panencephalitis, genital herpes the Varicella zoster virus (chicken pox and the shingles including recuring at patients with an immunodeficiency); Epstein-Barre's virus (infectious mononucleosis); cytomegalovirus; papillomavirus of the person; an acute and chronic viral hepatitis In (as a part of complex therapy);
- chronic recurrent respiratory infections and an urinogenital system at patients with the weakened immunity (including the clamidiosis and other diseases caused by intracellular activators), as a part of complex therapy.
Structure
Active ingredient - inosine pranobex (100 ml of syrup contain 5.0 g of inosine pranobex).
Excipients: sucrose, glycerin, methylparaben (E 218), propyl-parahydroxybenzoate (E 216), citrus fruit taste, the water purified.
Contraindication
- hypersensitivity to active ingredient or to any of medicament excipients;
- bad attack of gout;
- hyperuricemia.
Route of administration
Drug is taken inside, it is better - after a meal, at regular intervals. Duration of treatment is determined individually, depending on a nosology, by weights of process and frequency of a recurrence; duration of treatment averages 5-14 days, if necessary after a 7-10-day break the course of treatment is repeated. Treatment with breaks and maintenance doses can last to 1-6 months. The dosage is defined individually depending on age, body weight, weight of process.
Maximum daily dose - 4 g of inosine pranobex that corresponds to 80 ml of syrup.
Recommended doses and schemes of use of drug:
- flu, parainfluenza, acute respiratory viral infections (adult): 20 ml of syrup 3 - 4 times a day; children - a daily dose at the rate of 50 mg/kg (that is 1 ml of syrup/kg) body weights for 3-4 receptions within 5-7 days if necessary treatment to continue or repeat in 7-8 days; for achievement of the greatest efficiency in acute respiratory viral infections it is better to begin treatment at the first symptoms of a disease or from first day of a disease; as a rule, the medicament is taken by 1-2 more days after disappearance of symptoms;
- bronchitis of a virus etiology: adult - 20 ml of syrup 3 times a day, children - a daily dose at the rate of 50 mg/kg (that is 1 ml of syrup/kg) for 3-4 receptions within 2-4 weeks;
- epidemic parotitis: a daily dose at the rate of 70 mg/kg (that is 1.4 ml of syrup/kg) for 3-4 receptions within 7-10 days;
- measles: a daily dose at the rate of 100 mg/kg (that is 2 ml of syrup/kg) for 3-4 receptions within 7-14 days;
- stomatitis: adult - 20 ml of syrup 4 times a day, children - a daily dose at the rate of 70 mg/kg (that is 1.4 ml of syrup/kg) for 3-4 receptions within 6-8 days (sharp phase), further adult - 20 ml of syrup 3 times a day, children - 50 mg/kg (that is 1 ml of syrup/kg) for 3-4 receptions 2 times a week within 6 weeks;
- infectious mononucleosis: a daily dose at the rate of 50 mg/kg (that is 1 ml of syrup/kg) for 3-4 receptions within 8 days;
- Cytomegaloviral infection: a daily dose at the rate of 50 mg/kg (that is 1 ml of syrup/kg) for 3-4 receptions within 25-30 days;
- shingles and labial herpes: adult - 20 ml of syrup 3-4 times a day, children - a daily dose at the rate of 50 mg/kg (that is 1 ml of syrup/kg) for 3-4 receptions within 10-14 days (before disappearance of symptoms);
- genital herpes: during an acute period - on 20 ml of syrup 3 times a day within 5-6 days during remission a maintenance dose - on 20 ml of syrup (1000 mg) of 1 times a day up to 6 months;
- subacute sclerosing panencephalitis: a daily dose at the rate of 50-100 mg/kg (that is 1-2 ml of syrup/kg) for 6 receptions (each 4 hours) within 8-10 days after a 8-day break at an easy course in addition 1-3 more courses, at a heavy course - to 9 courses;
- an infection, the caused Human papilloma virus (peaked condylomas): on 20 ml of syrup 3 times a day, a course of treatment - 14-28 days or in a combination with cryotherapy or WITH 2 - laser therapy - 20 ml of syrup 3 times a day 3 courses at an interval of 1 month;
- hepatitis B: adult - 20 ml of syrup 3-4 times a day within 15-30 days further a maintenance dose - on 20 ml of syrup (1000 mg) of 1 times a day within 2-6 months;
- chronic recurrent respiratory infections and an urinogenital system at patients with the weakened immunity (in complex treatment): adult - 20 ml of syrup 3-4 times a day, a course of treatment - from 2 weeks to 3 months, children - a daily dose at the rate of 50 mg/kg (that is 1 ml of syrup/kg) for 3-4 receptions within 21 day (or 3 courses for 7-10 days with the same breaks).
For restoration of function of the immune system and achievement of steady immunomodulatory effect at patients with the weakened immunity the course of treatment has to last from 3rd to 9 weeks.
Feature of use
Pregnant
is not recommended to appoint Drug during pregnancy or feeding a breast due to the lack of clinical trials of use during pregnancy and feeding by a breast.
Children
Applyto children aged from one year.
Drivers
did not study Influence on ability to run motor transport or other mechanisms. However for decision-making on driving or work with mechanisms it is necessary to consider that medicament can cause dizziness or other side reactions from nervous system.
OverdoseCases of overdose were not observed by
. The overdose can cause increase in concentration of uric acid in blood serum and in urine. At overdose the gastric lavage and symptomatic therapy are shown. Side effects
Most typical side reaction at treatment inosine pranobeksy adults and children is temporary increase in level of uric acid in blood serum and in urine which return to initial normal values in several days after the end of treatment.
Storage conditionsto Store
at a temperature not above 25 °C, in the place, dry and inaccessible for children.
Expiration date - 3 years (after opening of a bottle - 3 months).
Characteristics | |
Active ingredients | Inosine pranobex |
Amount of active ingredient | 50 mg/ml |
Applicant | Roket-pharm |
Code of automatic telephone exchange | J05AX05 Inosine pranobex |
Interaction with food | Later |
Light sensitivity | Not sensitive |
Market status | Traditional |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | bottle |
Producer | S.P.A. AVS PHARMACHEUTICHI. |
Quantity in packing | 120 ml |
Release form | syrup |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Normomed |
Normomed syrup 50mg/ml fl. 120 ml
- Product Code: 183042
- In Stock
- Ready to ship
-
$25.14